Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 103915
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103915
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103915
Table 1 The binding energy of potential targets and contacts (kcal/mol)
Potential targets | Affinity (kcal/mol) | Contacts |
ACE | -4.37 | ALA-356 ASP-358 |
MMP2 | -7.35 | ALA-136 LEU-137 HIS-120 ARG-149 |
MMP9 | -7.35 | ALA-189 PRO-246 ALA-242 LEU-243 ARG-249 |
SI | -3.09 | GLU-687 ARG-682 ILE-763 ASP-796 GLU-678 |
AKR1B1 | -9.35 | ALA-299 LEU-300 SER-302 |
MGAM | -4.64 | CYS-15 PHE-161 ASN-71 |
HK1 | -2.22 | ASP-648 |
MMP1 | -5.5 | GLU-135 LYS-151 PHE-149 SER-142 |
IL-2 | -4.43 | GLU-60 ASN-90 SER-87 GLU-67 |
STAT3 | -2.78 | TYR-686 LYS-573 ALA-578 LEU-577 LEU-579 |
- Citation: Zheng XZ, Yu HY, Chen YR, Fang JS. Aucubin mitigates the elevation of microglial aerobic glycolysis and inflammation in diabetic neuropathic pain via aldose reductase. World J Diabetes 2025; 16(5): 103915
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/103915.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.103915